FDA Hopes To Resolve OTC Labeling Issues At Three Upcoming Meetings
This article was originally published in The Rose Sheet
Executive Summary
FDA will meet with cosmetics and over-the-counter drug trade associations as many as three more times to discuss outstanding concerns regarding the OTC labeling final rule.